Biotech Entrepreneurs Launch Agathos Biologics
b'Agathos Biologics , a biotechnology company developing transformational science in biomanufacturing, biologic payload delivery, and cell and gene therapy within a strong ethical and moral framework, today announced the launch of its research and development operations.
- b'Agathos Biologics , a biotechnology company developing transformational science in biomanufacturing, biologic payload delivery, and cell and gene therapy within a strong ethical and moral framework, today announced the launch of its research and development operations.
- View the full release here: https://www.businesswire.com/news/home/20210421005234/en/\nFounders of Agathos Biologics (Photo: Business Wire)\nThe company was founded by biotechnology entrepreneurs James Brown, Michael Chambers and John Ballantyne to pursue innovations in biotechnology that create value by positively impacting the health and welfare of society.
- Prior to Aldevron Brown helped launch Regenxbio in 2008, serving as Vice President of Technical Operations until 2015.
- \xe2\x80\x9c\xe2\x80\x99 Agathos Biologics \xe2\x80\x93 Good Science for a Better World \xe2\x80\x99 describes the company and our approach and is publicly available on our web site.\xe2\x80\x9d\nAgathos Biologics is a biotechnology company pursuing transformational science in biomanufacturing, biologic payload delivery, and cell and gene therapy.